Two published trials from the last two years tracked real under-eye pigmentation change over 6 to 12 weeks. Here is what the actual numbers show once the marketing language is stripped away.
· 6 min read
Under-eye dark circles get treated like one problem with one fix, but the phrase covers at least three different physical causes, and most eye creams are only built to address one of them. Two formulations published real trial data in the last two years, and reading those numbers side by side says more about realistic timelines than any product label does.
Dermatology sources group under-eye darkening into three mechanisms. The first is pigmented: sun exposure and normal melanin production darken the thin skin under the eye the same way it darkens anywhere else on the face [1]. The second is vascular: as skin below the eye loosens and thins with age, the blood vessels sitting close to the surface become easier to see through it, which reads as a blue or purple tint rather than brown [4]. The third is structural: a hollow tear trough forms where the lower eyelid meets the cheek, and the resulting shadow looks like a dark circle even when pigment and blood vessels are unremarkable [4]. A cream aimed at pigment will do close to nothing for a shadow caused by bone structure, which is a large part of why so many people feel like nothing works.
A study published in the Journal of Cosmetic Dermatology followed 37 women, ages 35 to 60, using a topical containing vitamin C (as tetrahexyldecyl ascorbate), caffeine, bioavailable peptides and botanical extracts, applied twice daily for 12 weeks [3]. The headline number is a 20 percent median improvement in dark circle appearance at week 12, measured against baseline photography and colorimeter readings, with a smaller but still statistically significant 12 percent improvement visible at week 4 [3]. Puffiness improved by 16.7 percent and overall periorbital appearance by 14.3 percent over the same period. A secondary measurement of microcirculation, essentially how well blood is moving through the small vessels in that area, improved by 49 percent by week 8, which the researchers linked to the reduction in the blue-purple vascular tint specifically [3]. Subjectively, 86.5 percent of participants agreed the area looked improved by the end of the study, and only two of the 37 reported mild dryness, which resolved before the trial ended [3].
A separate open-label trial published in the same journal in mid-2025 tested a different formula entirely: niacinamide, natural arbutin, a curcuma extract, and tranexamic acid, an ingredient more commonly associated with oral treatment of uneven tone that has increasingly shown up in topical form [2]. Fifty-three subjects applied the serum twice daily for 6 weeks, with pigmentation quantified through standardized imaging rather than a subjective rating scale. The result was an average 47.94 percent reduction in measured under-eye hyperpigmentation, split almost evenly between the right eye (48.44 percent) and left eye (47.43 percent), with a reported p-value under 0.0001 indicating the change was very unlikely to be due to chance [2]. A follow-up 20-subject safety arm reported no adverse effects across either group [2].
It is tempting to read these back to back and conclude the second formula is roughly double as effective, but the studies measured different things in different ways. The 2023 trial leaned on a mix of colorimeter data and subject-reported satisfaction across a longer 12-week window; the 2025 trial relied on standardized camera imaging over a shorter 6-week window and did not report a comparable satisfaction figure [2][3]. Neither trial included a placebo arm or a head-to-head comparison against the other formula, and both were funded by the companies whose products were being tested, which is standard for this category of research but still worth knowing before treating either percentage as a universal outcome. What both studies agree on is the shape of the timeline: visible change did not show up in the first week for either formula. The earliest statistically meaningful improvement in either trial appeared around week 4, and the larger, more convincing numbers arrived closer to weeks 8 through 12 [2][3].
Both trials targeted pigment and, to a lesser extent, the vascular tint from thinning skin. Neither ingredient set does anything for the third cause: a structural shadow from a hollow tear trough. That kind of shadowing typically needs volume added back, through an injectable filler or a similar in-office procedure, rather than a topical, because there is no pigment or blood vessel to lighten in the first place [4]. Under-eye darkness can also track with allergies, thyroid changes, anemia, or simply genetics, none of which a topical serum is designed to touch, and a healthcare provider is the right resource for ruling those out rather than a longer ingredient list [1]. Sun exposure is also worth naming directly: the same UV exposure that darkens pigment anywhere else on the face darkens the thin skin under the eyes, so daily sunscreen use around that area works alongside either formula rather than instead of it [1][4].
The practical read from both trials is that consistency matters more than which specific active is chosen. Twice-daily application for at least 8 weeks, not 8 days, is what both studies actually tested, so judging a new product before then is judging it against data it was never built to produce. Pairing either formula with daily SPF around the eye area addresses the pigment side of the equation directly, since new UV exposure works against whatever a serum is trying to fade [1]. Cold compresses remain a reasonable same-day step for the puffiness and vascular tint, since constricting blood vessels has an immediate, if temporary, effect independent of any active ingredient [4]. For a shadow that looks structural rather than discolored, a topical is the wrong tool regardless of brand, and that is worth ruling out before buying a third eye cream.
The two most recently published trials on under-eye darkening did not agree on which ingredients to use, but they agreed on the timeline: real, measured change showed up between weeks 4 and 12, not overnight. Before judging any under-eye product, use it as tested, twice daily for at least eight weeks, and pair it with daily sun protection around the eye area. If the appearance is more shadow than discoloration, that is a structural issue a cream was never going to solve, and it is worth having that conversation with a provider before buying another one.
Rituelle reads your skin over time and adapts your routine to it.
Get the app
Dryness & Barrier
Urea is usually filed under humectant and forgotten, but published reviews show it also boosts how much of whatever you apply next gets into skin. That is a real interaction, not a mixing myth, and it changes how you should layer it.
5 min read
Pairing & Conflicts
The warning against combining niacinamide and vitamin C traces to a single 1962 hydrolysis experiment on dry powder, not a finished skincare formula. Here is what that study actually measured and why it does not apply to the products on your shelf.
5 min read
Dryness & Barrier
Honey is back as a buzzy skincare ingredient, but a controlled hand-cream trial found something the trend pieces skip: strong hydration gains that did not come with a matching drop in water loss.
5 min read
